Sachin Mittal, Ph.D. - Publications

Affiliations: 
2005 University of Michigan, Ann Arbor, Ann Arbor, MI 
Area:
Pharmacy

10 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Doty AC, Zhang Y, Weinstein DG, Wang Y, Choi S, Qu W, Mittal S, Schwendeman SP. Mechanistic analysis of triamcinolone acetonide release from PLGA microspheres as a function of varying in vitro release conditions. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V. PMID 27865933 DOI: 10.1016/J.Ejpb.2016.11.008  0.5
2016 Zhang Y, Wischke C, Mittal S, Mitra A, Schwendeman SP. Design of controlled release PLGA microspheres for hydrophobic fenretinide. Molecular Pharmaceutics. PMID 27144450 DOI: 10.1021/Acs.Molpharmaceut.5B00961  0.514
2014 Dahan A, Wolk O, Yang P, Mittal S, Wu Z, Landowski CP, Amidon GL. Dipeptidyl peptidase IV as a potential target for selective prodrug activation and chemotherapeutic action in cancers. Molecular Pharmaceutics. 11: 4385-94. PMID 25365774 DOI: 10.1021/Mp500483V  0.662
2010 Wischke C, Zhang Y, Mittal S, Schwendeman SP. Development of PLGA-based injectable delivery systems for hydrophobic fenretinide. Pharmaceutical Research. 27: 2063-74. PMID 20668921 DOI: 10.1007/S11095-010-0202-Y  0.518
2007 Mittal S, Tsume Y, Landowski CP, Lee KD, Hilfinger JM, Amidon GL. Proline prodrug of melphalan, prophalan-L, demonstrates high therapeutic index in a murine melanoma model. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft FüR Pharmazeutische Verfahrenstechnik E.V. 67: 752-8. PMID 17560100 DOI: 10.1016/J.Ejpb.2007.03.024  0.681
2007 Mittal S, Song X, Vig BS, Amidon GL. Proline prodrug of melphalan targeted to prolidase, a prodrug activating enzyme overexpressed in melanoma. Pharmaceutical Research. 24: 1290-8. PMID 17377743 DOI: 10.1007/S11095-007-9249-9  0.624
2005 Mittal S, Song X, Vig BS, Landowski CP, Kim I, Hilfinger JM, Amidon GL. Prolidase, a potential enzyme target for melanoma: design of proline-containing dipeptide-like prodrugs. Molecular Pharmaceutics. 2: 37-46. PMID 15804176 DOI: 10.1021/Mp049922P  0.719
2004 Kim I, Song X, Vig BS, Mittal S, Shin HC, Lorenzi PJ, Amidon GL. A novel nucleoside prodrug-activating enzyme: substrate specificity of biphenyl hydrolase-like protein. Molecular Pharmaceutics. 1: 117-27. PMID 15832508 DOI: 10.1021/Mp0499757  0.627
2003 Vig BS, Lorenzi PJ, Mittal S, Landowski CP, Shin HC, Mosberg HI, Hilfinger JM, Amidon GL. Amino acid ester prodrugs of floxuridine: synthesis and effects of structure, stereochemistry, and site of esterification on the rate of hydrolysis. Pharmaceutical Research. 20: 1381-8. PMID 14567631 DOI: 10.1023/A:1025745824632  0.687
2003 Shin HC, Landowski CP, Sun D, Vig BS, Kim I, Mittal S, Lane M, Rosania G, Drach JC, Amidon GL. Functional expression and characterization of a sodium-dependent nucleoside transporter hCNT2 cloned from human duodenum. Biochemical and Biophysical Research Communications. 307: 696-703. PMID 12893280 DOI: 10.1016/S0006-291X(03)01259-2  0.679
Show low-probability matches.